NewsBenzingaHC 웨인라이트, 인히브릭스 바이오사이언스 투자의견 ‘매수’ 유지·목표주가 220달러로 하향 조정 HC 웨인라이트, 인히브릭스 바이오사이언스 투자의견 ‘매수’ 유지·목표주가 220달러로 하향 조정 Benzinga 2026.11.16 12:33 (GMT+0) Open on Benzinga Other news Creative Realities Q3 EPS $(0.29) Misses $(0.28) Estimate, Sales $26.208M Beat $26.067M Estimate HC Wainwright & Co. Maintains Buy on Inhibrx Biosciences, Lowers Price Target to $220 FitLife Brands Q3 EPS $0.16 Misses $0.25 Estimate, Sales $25.620M Miss $26.800M Estimate Montauk Renewables Q3 EPS $0.01 Misses $0.04 Estimate, Sales $50.192M Miss $53.270M Estimate Edible Garden AG Q3 EPS $(1.60) Beats $(1.96) Estimate, Sales $3.211M Beat $3.099M Estimate UBS Upgrades Telefonica Brasil to Neutral